Published in Clin Infect Dis on June 15, 2016
Novel Immunotherapies for Autoimmune Hepatitis. Front Pediatr (2017) 0.75
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology (2003) 16.40
Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet (2003) 7.94
Epidemiology of viral hepatitis and HIV co-infection. J Hepatol (2005) 6.41
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet (2014) 3.31
Cohort profile: the Swiss HIV Cohort study. Int J Epidemiol (2009) 3.05
The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection. Hepatology (2013) 2.98
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol (2005) 2.27
The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients. Clin Infect Dis (2006) 2.08
Hepatitis C. Lancet (2015) 1.95
Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis (2003) 1.93
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS (2008) 1.66
Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study. Ann Intern Med (2014) 1.64
HIV cohort collaborations: proposal for harmonization of data exchange. Antivir Ther (2004) 1.53
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA. HIV Med (2013) 1.28
Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp Hepatol (2005) 1.25
Cohort profile: the Canadian HIV-hepatitis C co-infection cohort study. Int J Epidemiol (2009) 1.17
Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997. Gastroenterology (2012) 1.13
Coinfection by human immunodeficiency virus and hepatitis C virus: noninvasive assessment and staging of fibrosis. Curr Opin Infect Dis (2012) 0.96
HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998-2008. J Hepatol (2011) 0.91
Long interval between HCV infection and development of hepatocellular carcinoma. Liver (1995) 0.90
Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH. J Hepatol (2011) 0.89
Influence of antiretroviral therapy on liver disease. Curr Opin HIV AIDS (2011) 0.89
Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain. Clin Infect Dis (2012) 0.88
Liver-related death among HIV/hepatitis C virus-co-infected individuals: implications for the era of directly acting antivirals. AIDS (2015) 0.85
The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection. J Acquir Immune Defic Syndr (2015) 0.83
CD4 recovery on antiretroviral therapy is associated with decreased progression to liver disease among hepatitis C virus-infected injecting drug users. Open Forum Infect Dis (2015) 0.80
HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma. AIDS (2014) 0.79
The effect of churn on "community viral load" in a well-defined regional population. J Acquir Immune Defic Syndr (2013) 0.77
Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service. Clinicoecon Outcomes Res (2014) 0.82
Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland. J Virus Erad (2016) 0.75
A pilot study of brisk walking in sedentary combination antiretroviral treatement (cART)- treated patients: benefit on soluble and cell inflammatory markers. BMC Infect Dis (2017) 0.75
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project. New Microbiol (2015) 0.75
HEFFICON: HIV Effectiveness Italian Conference. New Microbiol (2015) 0.75
Imaging patterns of Pneumocystis jirovecii pneumonia in HIV-positive and renal transplant patients - a multicentre study. Swiss Med Wkly (2019) 0.75